Association of systemic inflammatory markers with prognosis in erlotinib-treated EGFR-mutant non-small cell lung cancer.

Autor: Yetişir, Abdullah Evren1 evrenyetisir@hotmail.com, Paydaş, Semra2, Büyükşimşek, Mahmut1, Oğul, Ali1, Kolsuz, İrem3, Kıdı, Mehmet Mutlu2
Zdroj: Journal of Cancer Research & Therapeutics. Jan-Mar2024, Vol. 20, p285-288. 4p.
Databáze: Academic Search Ultimate